Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Avaxim 80U Pediatric in Healthy Children in China
NCT02011763Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2013
- Primary completion
- Sep 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Avaxim Junior in hepatitis A (HAV), sponsored by Sanofi. Started Dec 2013; status: completed.
02
Drugs
Avaxim Junior
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT02011763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02011763.